This fact sheet describes how the START-UP project is working with private-sector partners to develop two new tests that detect infection with the types of human papillomavirus (HPV) that cause cervical cancer. Designed for use in low-resource settings, these screening tools are an innovative answer to the challenge of early detection of the precursors of cervical cancer.
Corporate author(s): PATH
Publication date: July 2009
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- About PATH's work > Advancing technologies
- Health technologies > Diagnostic technologies
- Reproductive health > Cervical cancer prevention
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA